XML 19 R8.htm IDEA: XBRL DOCUMENT v3.3.1.900
Interim Condensed Consolidated Statements Of Cash Flows - USD ($)
$ in Thousands
 3 Months Ended
Jan. 01, 2016
Dec. 26, 2014
Operating activities:    
Net income including controlling interest $ 31,011 $ 41,937
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation and amortization 21,814 16,524
Stock-based compensation 19,380 17,842
Amortization of premium on investments 1,605 2,391
Excess tax benefit from exercise of stock options (300) (1,944)
Provision for doubtful accounts (322) (376)
Deferred income taxes (10,488) (6,310)
Other non-cash items affecting net income 445 653
Changes in operating assets and liabilities:    
Accounts receivable 11,961 (22,442)
Inventories (877) (2,997)
Prepaid expenses and other assets (3,567) (4,473)
Accounts payable and other liabilities (14,574) (46,801)
Income taxes, net 5,014 3,692
Deferred revenue 6,319 4,452
Other non-current liabilities (26) 1,297
Net cash provided by operating activities 67,395 3,445
Investing activities:    
Purchase of investments (85,299) (110,508)
Proceeds from sales of investment securities 121,770 63,454
Proceeds from maturities of investment securities 14,610 42,700
Purchases of property, plant and equipment (24,368) (21,661)
Payments for business acquisitions, net of cash acquired 0 (93,516)
Purchases of intangible assets (105,270) (6,416)
Proceeds from sale of property, plant and equipment and assets held for sale 0 3
Change in restricted cash (1,395) 102
Net cash provided by/(used in) investing activities (79,952) (125,842)
Financing activities:    
Proceeds from issuance of common stock 9,986 7,512
Repurchase of common stock (39,449) (16,953)
Payment of cash dividend (12,114) (10,228)
Distribution to controlling interest (214) (5,591)
Excess tax benefit from the exercise of stock options 300 1,944
Shares repurchased for tax withholdings on vesting of restricted stock (9,839) (10,846)
Net cash used in financing activities (51,330) (34,162)
Effect of foreign exchange rate changes on cash and cash equivalents (940) (2,798)
Net increase/(decrease) in cash and cash equivalents (64,827) (159,357)
Cash and cash equivalents at beginning of period 531,926 568,472
Cash and cash equivalents at end of period 467,099 409,115
Supplemental disclosure:    
Cash paid for income taxes, net of refunds received 13,973 13,739
Change in PP&E purchased and unpaid at period-end (3,636) 33,260
Noncash or Part Noncash Acquisition, Consideration Payable $ 95 $ 740